J&J reaches $6m settlement over counterfeit surgical tools
09-02-2021
Johnson & Johnson unit settles patent dispute over hypertension drug
28-01-2021
Gil C / Shutterstock.com
The US Court of Appeals for the Federal Circuit has affirmed a Patent Trial and Appeal Board (PTAB) decision that said patent claims owned by Ethicon, a subsidiary of Johnson & Johnson (J&J), are invalid.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Ethicon, Johnson & Johnson, patent, PTAB, USPTO, US Court of Appeals for the Federal Circuit, medical devices, inter partes review,
